TRODELVY

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug TRODELVY contains one active pharmaceutical ingredient (API):

1 Sacituzumab govitecan UNII M9BYU8XDQ6 - SACITUZUMAB GOVITECAN

Sacituzumab govitecan binds to Trop-2-expressing cancer cells and is internalised with the subsequent release of SN-38 from a hydrolysable linker. SN-38 interacts with topoisomerase I and prevents re-ligation of topoisomerase I-induced single strand breaks. The resulting DNA damage leads to apoptosis and cell death. Read about Sacituzumab govitecan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRODELVY Powder for solution for infusion	FDA, National Drug Code (US)	MPI, US: SPL/PLR
TRODELVY Powder for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FX17		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FX Other monoclonal antibodies
Discover more medicines within L01FX17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1867800
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 159417
Country: FR	Base de données publique des médicaments	Identifier(s): 67719704
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9256
Country: IT	Agenzia del Farmaco	Identifier(s): 049780012
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1093692
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100460464
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68365001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698760790310
Country: US	FDA, National Drug Code	Identifier(s): 55135-132